Kaposi sarcoma-associated herpesvirus latency-associated nuclear antigen: more than a key mediator of viral persistence

Curr Opin Virol. 2023 Aug:61:101336. doi: 10.1016/j.coviro.2023.101336. Epub 2023 Jun 16.

Abstract

Kaposi sarcoma-associated herpesvirus (KSHV), or human herpesvirus-8, is an oncogenic herpesvirus. Its latency-associated nuclear antigen (LANA) is essential for the persistence of KSHV in latently infected cells. LANA mediates replication of the latent viral genome during the S phase of a dividing cell and partitions episomes to daughter cells by attaching them to mitotic chromosomes. It also mediates the establishment of latency in newly infected cells through epigenetic mechanisms and suppresses the activation of the productive replication cycle. Furthermore, LANA promotes the proliferation of infected cell by acting as a transcriptional regulator and by modulating the cellular proteome through the recruitment of several cellular ubiquitin ligases. Finally, LANA interferes with the innate and adaptive immune system to facilitate the immune escape of infected cells.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antigens, Viral / genetics
  • Herpesvirus 8, Human* / genetics
  • Humans
  • Nuclear Proteins / genetics
  • Nuclear Proteins / metabolism
  • Sarcoma, Kaposi*
  • Virus Latency / genetics

Substances

  • latency-associated nuclear antigen
  • Nuclear Proteins
  • Antigens, Viral